当前位置:主页 > 医学论文 > 妇产科论文 >

B7-H4和PAX2在子宫内膜癌中的表达及临床意义

发布时间:2019-04-10 13:51
【摘要】:目的: 1.观察B7-H4、 PAX2在子宫内膜癌、子宫内膜增生症、正常子宫内膜组织中的表达及其与子宫内膜癌病理的关系,,研究B7-H4和PAX2在子宫内膜癌组织中发生发展的相关性。 2.研究B7-H4、PAX2的表达在子宫内膜癌组织中是否有一定的相关性。 结果: 1.B7-H4在子宫内膜癌、子宫内膜增生症、正常子宫内膜组织中的阳性表达有统计学意义(p0.05),PAX2的阳性表达比较也有统计学意义(p0.05)。 2. PAX2在子宫内膜样腺癌中的阳性率为:87.23%,在非内膜样癌中的阳性率为:22.22%,两者之间有统计学意义P=0.048(P0.05)。 3. B7-H4在子宫内膜癌手术-病理分期Ⅰ-Ⅱ期阳性表达率为75.00%,Ⅲ—Ⅳ期为100.00%,Ⅲ—Ⅳ期的表达高于Ⅰ-Ⅱ期,两者之间表达比较:P值=0.020(P<0.05),差异有统计学意义。PAX2在子宫内膜癌手术-病理分期中Ⅰ-Ⅱ期阳性表达率为37.50%,Ⅲ—Ⅳ期为77.78%,Ⅲ—Ⅳ期的表达高于Ⅰ-Ⅱ期,两者之间表达比较:P值=0.006(P<0.01),统计学比较有显著性差异。 4. PAX2在子宫内膜癌中的表达随组织学分级的升高而上升:G1:28.57%、G2:64.44%、G3:75.00%,统计学有显著性差异(P=0.004X2=8.26)。 5. B7-H4在有淋巴结转移的阳性表达率(100.00%)高于无淋巴结转移的阳性表达率(77.14%),两者之间比较P值=0.028(P<0.05),有统计学意义。PAX2在有淋巴结转移的阳性表达率(73.33%)高于无淋巴结转移的阳性表达率(42.86%),两者之间比较P值=0.047(P<0.05),有统计学意义。 6.经SPSS13.0软件分析子宫内膜癌中B7-H4、 PAX2的表达,结果显示Spearman等级相关系数为0.481,P=0.025,可以认为子宫内膜癌组织中,B7-H4和突变型PAX2表达在统计学上存在正相关。 结论: B7-H4、 PAX2在子宫内膜癌的发生发展中可能起到一定的作用。两者在子宫内膜癌中的表达在统计学中呈正相关。
[Abstract]:Purpose: 1. To observe the expression of B7 / H4 and PAX2 in endometrial carcinoma, endometrial hyperplasia and normal endometrium, and to study the relationship between the expression of B7H4 and PAX2 and the pathogenesis of endometrial carcinoma, and to study the correlation between B7H4 and PAX2 in endometrial carcinoma. 2. To investigate the correlation between the expression of B7 / H4 and PAX2 in endometrial carcinoma. Results: the positive expression of 1.B7-H4 was statistically significant in endometrial carcinoma, endometrial hyperplasia and normal endometrium (p0.05), and the positive expression of PAX2 was also statistically significant (p0.05). 2. The positive rate of PAX2 was 87.23% in endometrioid adenocarcinoma and 22.22% in non-endometrioid carcinoma. There was significant difference between the two groups (P0.05). 3. The positive expression rate of B7-H4 in stage 鈪

本文编号:2455847

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/fuchankeerkelunwen/2455847.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户40618***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com